Eyal Raz

Eyal Raz

Auto-generated profile, based on publicly available information

Eyal Raz

University of California, San Diego

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2012 in Nature Reviews Immunology
Verified
Journal Article
Closed access
PDF file
JGJosé M. González-Navajas
José M. González-Navajas
JLJongdae Lee
Jongdae Lee
MDMichael David
Michael David
EREyal Raz
Eyal Raz

1 February 2004 in Gastroenterology
Verified
Journal Article
Open access
PDF file
DRDaniel Rachmilewitz
Daniel Rachmilewitz
KKKyoko Katakura
Kyoko Katakura
FKFanny Karmeli
Fanny Karmeli
THTomoko Hayashi
Tomoko Hayashi
CRConstantin Reinus
Constantin Reinus
EREyal Raz
Eyal Raz
: We tested whether the attenuation of experimental colitis by live probiotic bacteria is due to their immunostimulatory DNA, whether toll-like receptor (TLR) signaling is required, and whether nonviable probiotics are effective. : Methylated and unmethylated genomic DNA isolated from probiotics (VSL-3), DNAse-treated probiotics and Escherichia coli (DH5α) genomic DNA were administered intragastricly (i.g.) or subcutaneously (sc) to mice prior to the induction of colitis. Viable or γ-irradiated probiotics were administered i.g. to wild-type mice and mice deficient in different TLR or in the adaptor protein MyD88, 10 days prior to administration of dextran sodium sulfate (DSS) to their drinking water and for 7 days thereafter. : ntragastric and sc administration of probiotic and E. coli DNA ameliorated the severity of DSS-induced colitis, whereas methylated probiotic DNA, calf thymus DNA, and DNase-treated probiotics had no effect. The colitis severity was attenuated to the same extent by i.g. delivery of nonviable γ-irradiated or viable probiotics. Mice deficient in MyD88 did not respond to γ-irradiated probiotics. The severity of DSS-induced colitis in TLR2 and TLR4 deficient mice was significantly decreased by i.g. administration of γ-irradiated probiotics, whereas, in TLR9-deficient mice, γ-irradiated probiotics had no effect. : The protective effects of probiotics are mediated by their own DNA rather than by their metabolites or ability to colonize the colon. TLR9 signaling is essential in mediating the anti-inflammatory effect of probiotics, and live microorganisms are not required to attenuate experimental colitis because nonviable probiotics are equally effective.

1 May 2002 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
DRDaniel Rachmilewitz
Daniel Rachmilewitz
FKFanny Karmeli
Fanny Karmeli
KTKenji Takabayashi
Kenji Takabayashi
THTomoko Hayashi
Tomoko Hayashi
LLLeonor Leider-Trejo
Leonor Leider-Trejo
EREyal Raz
Eyal Raz

15 April 2003 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
SDSandip Datta
Sandip Datta
VRVanessa Redecke
Vanessa Redecke
KPKiley R. Prilliman
Kiley R. Prilliman
KTKenji Takabayashi
Kenji Takabayashi
MCMaripat Corr
Maripat Corr
EREyal Raz
Eyal Raz
Dendritic cells (DCs) are capable of cross-presenting exogenous Ag to CD8+ CTLs. Detection of microbial products by Toll-like receptors (TLRs) leads to activation of DCs and subsequent orchestration of an adaptive immune response. We hypothesized that microbial TLR ligands could activate DCs to cross-present Ag to CTLs. Using DCs and CTLs in an in vitro cross-presentation system, we show that a subset of microbial TLR ligands, namely ligands of TLR3 (poly(inosinic-cytidylic) acid) and TLR9 (immunostimulatory CpG DNA), induces cross-presentation. In contrast to presentation of Ag to CD4+ T cells by immature DCs, TLR-induced cross-presentation is mediated by mature DCs, is independent of endosomal acidification, and relies on cytosolic Ag processing machinery.

5 October 2014 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
SBSamuel Bertin
Samuel Bertin
YAYukari Aoki-Nonaka
Yukari Aoki-Nonaka
PJPetrus De Jong
Petrus De Jong
LNLilian L Nohara
Lilian L Nohara
HXHongjian Xu
Hongjian Xu
EREyal Raz
Eyal Raz

9 May 2010 in Nature Medicine
Verified
Journal Article
Open access
PDF file
SLSung Hee Lee
Sung Hee Lee
LHLi-Li Hu
Li-Li Hu
JGJosé M. González-Navajas
José M. González-Navajas
GSGeom Seog Seo
Geom Seog Seo
CSCarol Shen
Carol Shen
EREyal Raz
Eyal Raz
This study dissects the contribution of TLR signaling to intestinal tumorigenesis. MyD88 signaling, known to be required for tumorigenesis in Apcmin/+ mice, is shown to be triggered by ligands from the microflora. MyD88-mediated activation of the MEK-ERK cascade stabilizes c-Myc by preventing its ubiquitin-mediated degradation. The findings link oncogenic c-Myc function to immune signaling and uncover MEK inhibition as a new therapeutic strategy to treat intestinal tumors. Toll-like receptor (TLR) signaling is essential for intestinal tumorigenesis in Apcmin/+ mice, but the mechanisms by which Apc enhances tumor growth are unknown. Here we show that microflora-MyD88-ERK signaling in intestinal epithelial cells (IECs) promotes tumorigenesis by increasing the stability of the c-Myc oncoprotein. Activation of ERK (extracellular signal–related kinase) phosphorylates c-Myc, preventing its ubiquitination and subsequent proteasomal degradation. Accordingly, Apcmin/+/Myd88−/− mice have lower phospho-ERK (p-ERK) levels and fewer and smaller IEC tumors than Apcmin/+ mice. MyD88 (myeloid differentiation primary response gene 88)-independent activation of ERK by epidermal growth factor (EGF) increased p-ERK and c-Myc and restored the multiple intestinal neoplasia (Min) phenotype in Apcmin/+/Myd88−/− mice. Administration of an ERK inhibitor suppressed intestinal tumorigenesis in EGF-treated Apcmin/+/Myd88−/− and Apcmin/+ mice and increased their survival. Our data reveal a new facet of oncogene-environment interaction, in which microflora-induced TLR activation regulates oncogene expression and related IEC tumor growth in a susceptible host.